Publications
15
Citations
135
Est. group size
~6
Recurring co-author estimate
Active years
25
Publishing since 2001
Jean Truxall's research focuses on blood cancers, particularly acute myeloid leukemia (AML) and chronic lymphocytic leukemia (CLL), using mouse models to study how specific genetic mutations drive disease development and progression. Recent work examines how certain genes (like MYC, NPM1, FLT3, PTPN11) contribute to leukemia and lymphoma formation, and how the immune system responds to these cancers. This research aims to better understand disease mechanisms that could inform future treatment approaches.
Publication output has been modest but fairly steady over the last decade, with a slight increase in activity from 2022 to 2024.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Temporally Controlled MYC Overexpression in Chronic Lymphocytic Leukemia Accelerates Progression and Promotes Large B Cell Lymphoma Transformation
Blood · 2024
- Development of a Fully Immunocompetent Adoptive Transfer <i>In Vivo</i> Model of <i>Npm1 cA;Idh2 R140Q;Flt3 ITD</i> AML
Blood · 2023
- A Novel <i>Ptpn11</i>E76K/<i>Npm1</i>cA Murine Model of AML Identifies a Unique Immune Population Relevant to Human Disease
Blood · 2022
- Blood×6
- Cancer Research×5
- Journal of Hematology & Oncology×2
- JCI Insight×1
- Nicole R. Grieselhuber
Medicine · The Ohio State University
- Jae Yoon Jeon
Medicine · The Ohio State University
- Ying Huang
Medicine · The Ohio State University
- Mehdi Gharghabi
Medicine · The Ohio State University
- Brian Giacopelli
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile